SCHEMBL803197

SCHEMBL803197

CCN(C(=O)c1ccccc1C)[C@@H]1CCc2ccc(C(=O)OC)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
DRD3 P35462 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 1/20 0.37
ACHE P22303 1/20 0.37
RAB9A P51151 2/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
TRPM8 Q7Z2W7 2/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL803175 0.89 LMNA (0.39) LMNATP53DRD3KMT2AMEN1
SCHEMBL803508 0.89 WDR5 (0.41) TP53KMT2AMEN1MAPTACHE
SCHEMBL784639 0.89 DRD3 (0.41) DRD3KMT2AMEN1ACHEPOLB
SCHEMBL784638 0.89 DRD3 (0.41) DRD3KMT2AMEN1ACHEPOLB
SCHEMBL803576 0.86 LMNA (0.40) LMNATP53DRD3KMT2AMEN1
SCHEMBL803728 0.84 TRPM8 (0.39) LMNATP53DRD3KMT2AMEN1
SCHEMBL803734 0.84 SLC6A2 (0.41) LMNAKMT2AMEN1MAPTACHE
SCHEMBL883738 0.83 TSHR (0.40) LMNADRD3KMT2AMEN1MAPT
SCHEMBL803552 0.81 HCRTR1 (0.38) MAPTACHERAB9ANPC1ALDH1A1
SCHEMBL803218 0.81 TSHR (0.39) KMT2ASLC6A2SLC6A4SLC6A3TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
WO-2012038081-A1 SUBSTITUTED BENZAMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-03-29 WO disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 LMNA 1463/4885TP53 4295/4885DRD3 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.